Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
XOMA to Present at the Cantor Fitzgerald Healthcare Conference
-
Cambrex to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
NeuroDerm to Present at the Cantor Fitzgerald Healthcare Conference on July 13
-
Aclaris Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Cerus to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 13, 2016
-
Regulus to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Aimmune Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Alcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Cara Therapeutics to Webcast Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Mirna Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Sunesis Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Radius Health to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Nabriva to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
ArQule to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 12, 2016
-
Axsome Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
T2 Biosystems to Present at the Cantor Fitzgerald Healthcare Conference
-
Nicox to transfer Commercial Operations to new pan-European Ophthalmic Specialty Pharmaceutical Company led by GHO Capital
-
Vitae Pharmaceuticals (VTAE) Enters $40M ATM Offering
-
Veracyte to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Abeona Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Adamas Pharmaceuticals to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
ChemoCentryx to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Juniper Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference
-
Iroko Pharmaceuticals Secures Debt Financing From CRG
-
Dimension Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
DURECT to Present at the Cantor Fitzgerald Healthcare Conference
-
Nicox added to Russell Global Index
-
Sprott Enhances Flexibility for Accretive Growth for the Physical Silver and Physical Platinum and Palladium Trusts
-
Cyclacel Pharma (CYCC) Enters $4M At Market Issuance Sales Agreement
-
Eiger BioPharmaceuticals (EIGR) Enters $25M Stock Sales Agreement
-
Agile Therapeutics to Present at the Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Cantor Fitzgerald Starts Sabra Healthcare REIT Inc. (SBRA) at Buy
-
Cantor Fitzgerald Starts Healthcare Realty Trust (HR) at Hold
-
Cantor Fitzgerald Starts LTC Properties (LTC) at Buy
-
Cantor Fitzgerald Starts National Health Investors (NHI) at Hold
-
Cantor Fitzgerald Starts Physicians Realty Trust (DOC) at Buy
-
Luminex Corporation To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
ScienceLogic CEO Dave Link Named Ernst & Young Entrepreneur Of The Year(R) 2016 Mid-Atlantic Award Winner
-
Cross Country Healthcare to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
U.S. FDA grants Priority Review for Nicox's AC-170 New Drug Application
-
Conyers Park Acquisition Corp. Files Registration Statement for Initial Public Offering of Securities
-
Cantor Fitzgerald is Positive on Relypsa (RLYP) as Outpatient Prescriptions Grow Another 30+%
-
Hooper Holmes to Present at the Cantor Fitzgerald Healthcare Conference
-
Kew Media Group Inc. Announces Completion of $70,000,000 Initial Public Offering
-
Orchid Island Capital Announces June 2016 Monthly Dividend and May 31, 2016 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Starts Alcobra Ltd. (ADHD) at Buy
-
Kew Media Group Inc. Files Final Prospectus for Initial Public Offering of $70,000,000 of Class a Restricted Voting Units
-
Notable Analyst Rating Changes 6/3: (UNP) (DE) (WFT) Upgraded; (ICLR) (TSL) (PCAR) Downgraded
-
Pre-Open Stock Movers 06/03: (TLN) (IMMU) (AMBA) Higher; (WRES) (ONTY) (ZUMZ) Lower (more...)
-
Cantor Fitzgerald Starts Dimension Therapeutics (DMTX) at Buy

